Table 1 Multi-factor analysis of the prognosis in 245 patients with HG-SOC using the Cox regression

From: C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation

Factor

OS

PFS

 

Relative risk

95% CI

P

Relative risk

95% CI

P

C/EBPβ expression (low vs. high)

2.385

1.499–3.795

0.0002

4.201

2.928–6.028

6.72 × 10−15

Residual disease (R0 vs. R1)

3.516

2.203–5.610

1.34 × 10−6

2.176

1.523–3.109

1.93 × 10−5

Age at diagnosis (≤55 vs. >55 years)

–

–

0.359

–

–

0.314

FIGO stage (II vs. III, IV)

–

–

0.053

–

–

0.821

Ascites (no vs. yes)

–

–

0.428

–

–

0.581

  1. FIGO International Federation of Gynecology and Obstetrics, R0 no gross residual, R1 any residual
Back to article page